InnoCon Medical
UCon is a medical device for treatment of the symptoms of OAB and fecal incontinence (FI). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder musculature e.g., suppress undesired bladder activity to relieve the symptoms of the patient. This clinical investigation is a randomized, cross-over, single-site, prospective, early feasibility study, which is used to evaluate Ucon with respect to its initial clinical safety and device performance in a small number of males with OAB.
Urinary Incontinence
Urge Incontinence
Nocturia
Urinary Frequency More Than Once at Night
Urinary Incontinence, Urge
Incontinence, Nighttime Urinary
Urge stimulation
Time limited stimulation
Not Applicable
The purpose of the current investigation is to obtain information about the type of stimulation that Ucon provide (time limited vs. urge stimulation), would be the most effective and feasible for the treatment of non-neurogenic OAB symptoms in males.}}
Study Type : | Interventional |
Estimated Enrollment : | 20 participants |
Masking : | None (Open Label) |
Primary Purpose : | Treatment |
Official Title : | Safety and Performance of UCon for Management of Non-Neurogenic OAB in Males - An Early Feasibility Study |
Actual Study Start Date : | October 12, 2023 |
Estimated Primary Completion Date : | October 12, 2024 |
Estimated Study Completion Date : | October 12, 2024 |
Arm | Intervention/treatment |
---|---|
Other: Group A (Urge and Time limited) The participant self-administer electrical stimulation to the dorsal genital nerve (DGN) using UCon with a stimulation mode that is activated for 60 seconds by the participant when he experience urgency (urge stimulation).The urge stimulation can be activated repeatedly during the day as the participant wears the device from morning to evening at home for 14 days. Following a stimulation wash-out period (14 days), the participants then stimulates with UCon for another 14 days using the time limited stimulation mode. |
Device: Urge stimulation Device: Time limited stimulation |
Other: Group B (Time limited and Urge) The participant self-administer electrical stimulation to the dorsal genital nerve (DGN) using UCon with a stimulation mode that is activated for 30 minutes once a day, at a time that is convenient for the particiant. The participant uses the device at home for 14 days. Following a stimulation wash-out period (14 days), the participant then stimulates with UCon for another 14 days using the urge stimulation mode. |
Device: Urge stimulation Device: Time limited stimulation |
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | No |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Recruiting
Maastricht University Medical Center+
Maastricht, Netherlands,